Literature DB >> 4435012

Effect of oxotremorine on homovanillic acid concentration in the striatum of the rat.

T Nose, H Takemoto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4435012     DOI: 10.1016/0014-2999(74)90093-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  12 in total

1.  Chronic nicotine treatment changes differentially the effects of acute nicotine on the three main dopamine metabolites in mouse striatum.

Authors:  T Leikola-Pelho; J Heinämäki; I Laakso; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

2.  Effect of acute nicotine administration on striatal dopamine output and metabolism in rats kept at different ambient temperatures.

Authors:  T Seppä; M Ruotsalainen; I Laakso; R Tuominen; L Ahtee
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

3.  The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.

Authors:  O Salminen; T Seppä; H Gäddnäs; L Ahtee
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

4.  Differential response to cholinergic stimulation in psychogenitically selected rat lines.

Authors:  J R Martin; P Driscoll; C Gentsch
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Antagonism of the nicotine-induced changes of the striatal dopamine metabolism in mice by mecamylamine and pempidine.

Authors:  H Haikala; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

6.  Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.

Authors:  S Kaakkola; L Ahtee
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

7.  Possible cholinergic-dopaminergic link in memory facilitation induced by oxotremorine in mice.

Authors:  C M Baratti; I B Introini; P Huygens; F Gusovsky
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  Failure of anticholinergic drugs to antagonize the increase in dopamine seen after gammahydroxybutyric acid and axotomy.

Authors:  G Stock
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

9.  Involvement of both cholinergic and catecholaminergic pathways in the central action of methylphenidate: a study utilizing lead-exposed rats.

Authors:  R M Shih; Z S Khachaturian; I Hanin
Journal:  Psychopharmacology (Berl)       Date:  1977-12-19       Impact factor: 4.530

10.  Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion.

Authors:  K L Davis; K F Faull; L E Hollister; J D Barchas; P A Berger
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.